Skip to content

A clinical study to asses effectiveness of Hariras Ayurvedic Pills in management of Bad Breath.

A clinical validation of Hariras Ayurvedic Pills in management of halitosis. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064044
Enrollment
20
Registered
2024-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R196- Halitosis

Interventions

Intervention1: Hariras Ayurvedic Pills: One Hariras Ayurvedic pills 08 to 10 times per day for seven days. Control Intervention1: NIL: NIL

Sponsors

Sushrutkrupa Ayurvedic Pharmacy Pvt. Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age: 18 to 55 years (both inclusive) at the time of consent. 2. Sex: Healthy male and non-pregnant/non-lactating females. 3. Females of childbearing potential must have a negative urine pregnancy test performed on screening. 4. Subjects are in good general health as determined by the Investigator based on medical history. 5. Subjects having clinically relevant mouth malodor evident by Halimeter. 6. Subjects should be willing and able to follow the study directions to participate in the study. 7. Subject willing to come to study site without brushing and can stay for 6 hrs. for assessment of oral malodor.

Exclusion criteria

Exclusion criteria: 1. Subjects with orthodontic bands. 2. Subjects with plaque index of 0, 1 and 5 3. Subjects with partial removable dentures. 4. Subjects having tumor(s) of the soft or hard tissues of the oral cavity. 5. Subjects with advanced periodontal disease (purulent exudate, tooth mobility, and/or extensive loss of periodontal attachment or alveolar bone) 6. Subjects with ongoing antibiotic treatment at the time of screening. 7. Subjects having participated in any other dental clinical study within the last six months prior to entry into the study. 8. Subjects with dental prophylaxis during the past two weeks prior to baseline examinations. 9. Subjects with a history of allergies to any oral care/personal care consumer products or their ingredients. 10. Subjects on any prescription medicines that might interfere with the study outcome. 11. Pregnant and lactating women. 12. Subjects habitual to consumption of any medicated sweets, chewing gum, breath fresheners, etc. containing antimicrobial agents. 13. Subjects with diseases or having a history that potentially can contribute to oral malodor (e.g. diabetes mellitus, bronchitis, tonsillitis, sinusitis etc.) 14. Subjects habitual consumption of alcohol, tobacco, and smoking cigarettes.

Design outcomes

Primary

MeasureTime frame
1.To evaluate the effect of the test product on malodor control using a Halimeter from screening to end of the study. 2.Changes in subject-reported freshness score on 5-point scale from screening to end of the study. Timepoint: At Screening, Baseline, Day 1, Day 7

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactMr Manish Jayatilal Bhardwaj

Sushrutkrupa Ayurvedic Pharmacy Pvt. Ltd.

sushrutkrupa.ayurved@gmail.com9824254187

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026